Abstract:

Ethiopia is among the countries with a high burden of measles outbreaks. Moreover, studies investigating the burden of measles in Ethiopia, particularly those that systematically analyze measles cases at the subnational level and their determinants, are scarce. Hence, thirty years of measles data were extracted and evaluated from the Global Burden of Disease 2021 database. Descriptive statistics were used to quantify the overall burden of measles, including incidence, prevalence, deaths, and disability-adjusted life years (DALYs), and temporal trends from 1990 onwards were analyzed. Subnational disparities in measles burden were assessed to identify high-burden areas requiring targeted interventions. Uncertainty in the estimates was quantified through 1,000 iterations of the model, producing 95% uncertainty intervals (2.5th and 97.5th percentiles) for all metrics. Measles incidence, prevalence, death, and disability-adjusted life years were 709/100,000 (95% UI: 461.66-1017.29), 19/100,000 (95% UI: 12.65-27.87), 8/100,000 (95% UI: 4.28-14.35), and 728/100,000 (95% UI: 377.52-1264) in Ethiopia in 2021.Moreover, the national measles incidence rate decreased by 96% in 2021 compared to that of 1990. The measles burden was higher in the Afar, Somali, and Benishangul Gumuz regions and lower in Addis Ababa. After the introduction of the second dose of measles, there was a notable decrease in the burden. However, the measles burden remains substantial in Ethiopia, despite a notable decline over the past three decades. Therefore, our results suggest that there is an urgent need to improve measles vaccination service in Ethiopia, especially in high-burden regions.

References:

[1].   WHO, 2024, “Measles.” [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/measles. [Accessed: 19-Apr-2025].

[2].   WHO, 2024, “Immunization Coverage.” [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. [Accessed: 15-Mar-2025].

[3].   CDC, 2025, “Global Measles Outbreaks,” Global Measles Vaccination. [Online]. Available: https://www.cdc.gov/global-measles-vaccination/data-research/global-measles-outbreaks/index.html. [Accessed: 19-Apr-2025].

[4].   WHO, 2023, “Measles - Ethiopia.” [Online]. Available: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON460. [Accessed: 19-Apr-2025].

[5].   CDC, 2024, “Global Measles Outbreaks,” Global Measles Vaccination. [Online]. Available: https://www.cdc.gov/global-measles-vaccination/data-research/global-measles-outbreaks/index.html. [Accessed: 07-Dec-2024].

[6].   Bello, I. M., Akpan, G. U., Teshager, H. F., Jepkorir, L. E., and Girma, M. B., 2024, “Factors Influencing Recurrent Measles Outbreak in Ethiopia among Under-Five Children: A Systematic Review,” PAMJ-One Health, 15(7). https://doi.org/10.11604/pamj-oh.2024.15.7.43800.

[7].   WHO, 2024, “Immunization Coverage.” [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. [Accessed: 19-Apr-2025].

[8].   WUENIC, 2023, “Wuenic-Progress-and-Challenges.Pdf.” [Online]. Available: https://cdn.who.int/media/docs/default-source/immunization/wuenic-progress-and-challenges.pdf. [Accessed: 07-Dec-2024].

[9].   WHO, 2023, “WHO Immunization Data Portal,” Immunization Data. [Online]. Available: https://immunizationdata.who.int/global/wiise-detail-page. [Accessed: 07-Dec-2024].

[10].  Biks, G. A., Shiferie, F., Tsegaye, D. A., Asefa, W., Alemayehu, L., Wondie, T., Seboka, G., Hayes, A., RalphOpara, U., Zelalem, M., Belete, K., Donofrio, J., and Gebremedhin, S., 2024, “In-Depth Reasons for the High Proportion of Zero-Dose Children in Underserved Populations of Ethiopia: Results from a Qualitative Study,” Vaccine: X, 16, p. 100454. https://doi.org/10.1016/j.jvacx.2024.100454.

[11].  WHO, “Immunization Agenda 2030: A Global Strategy To Leave No One Behind.” [Online]. Available: https://www.who.int/publications/m/item/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind. [Accessed: 19-Apr-2025].

[12].  Gavi, 2023, “Catching up to the Challenge: Lessons Learned from Ethiopia’s Journey to Reach Missed Children.” [Online]. Available: https://www.gavi.org/vaccineswork/catching-challenge-lessons-learned-ethiopias-journey-reach-missed-children. [Accessed: 19-Apr-2025].

[13].  UNICEF, 2024, “Ethiopia (ETH) - Demographics, Health & Infant Mortality,” UNICEF DATA. [Online]. Available: https://data.unicef.org/country/eth/. [Accessed: 08-Dec-2024].

[14].  Worldometer, 2024, “Ethiopia Population (2024) - Worldometer.” [Online]. Available: https://www.worldometers.info/world-population/ethiopia-population/. [Accessed: 08-Dec-2024].

[15].  MOH, 2025, “Expanded Program on Immunization (EPI) | MINISTRY OF HEALTH - Ethiopia.” [Online]. Available: https://www.moh.gov.et/en/Expanded_Program_on_Immunization_%28EPI%29?language_content_entity=en. [Accessed: 19-Apr-2025].

[16].  Ferrari, A. J., Santomauro, D. F., Aali, A., and Abate, Y. H., 2024, “Global Incidence, Prevalence, Years Lived with Disability (YLDs), Disability-Adjusted Life-Years (DALYs), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021,” The Lancet, 403(10440), pp. 2133–2161. https://doi.org/10.1016/s0140-6736(24)00757-8.

[17].  Pepito, V. C., 2024, “Global Incidence, Prevalence, Years Lived with Disability (YLDs), Disability-Adjusted Life-Years (DALYs), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021,” Lancet, 403(10440), pp. 2133–2161. https://doi.org/10.1016/S0140-6736(24)00757-8.

[18].  Gavi, 2025, “Gender and Immunization.” [Online]. Available: https://www.gavi.org/our-alliance/strategy/gender-and-immunisation. [Accessed: 26-Apr-2025].

[19].  Edwards, K. M., 2015, “Maternal Antibodies and Infant Immune Responses to Vaccines,” Vaccine, 33(47), pp. 6469–6472. https://doi.org/10.1016/j.vaccine.2015.07.085.

[20].  WHO, 2019, “Ethiopia Launches Measles Vaccine Second Dose (MCV2) Introduction: Over 3.3 Million Children Will Receive the Vaccine Annually | WHO | Regional Office for Africa.” [Online]. Available: https://www.afro.who.int/news/ethiopia-launches-measles-vaccine-second-dose-mcv2-introduction-over-33-million-children-will. [Accessed: 30-Mar-2025].

[21].  Tamir, T. T., Zegeye, A. F., Mekonen, E. G., Tekeba, B., Ali, M. S., Gonete, A. T., Kassie, A. T., Workneh, B. S., Wassie, M., and Alemu, T. G., 2024, “Prevalence, Spatial Variation and Determinants of Zero-Dose Children in Ethiopia: Spatial and Multilevel Analyses,” Public Health, 236, pp. 365–372. https://doi.org/10.1016/j.puhe.2024.09.011.

[22].   WHO, 2023, “Measles - Ethiopia.” [Online]. Available: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON460. [Accessed: 15-Mar-2025].

[23].  WHO, “Disease Burden.” [Online]. Available: https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/surveillance/monitoring. [Accessed: 30-Mar-2025].